Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2011

View Archived Issues

TSRL discloses preclinical data on neuraminidase inhibitor prodrugs

GSK FLAP inhibitor attenuates allergen-induced asthma responses in phase II trials

MRI technique may aid in differentiating Gulf War illness variants

Study identifies SNPs associated with severity of A/H1N1/2009 influenza in children

Protalix Biotherapeutics patents novel cross-linked multimeric proteins for Gaucher's disease

Promising phase III data disclosed on VX-770 in CF

AXL-1717 benefits patients with advanced-stage NSCLC in phase I trial

Scientists in Taiwan identify miRNA signature associated with incidence of oral cancer

Amgen discloses novel series of beta-secretase 1 inhibitors

Novel prostanoid DP1 receptor antagonists synthesized by Sanofi

New TRPA1 channel antagonists presented by Glenmark Pharmaceuticals

Novel agents for bacterial infections claimed

New SSAO inhibitors described by Proximagen

FDA approves Merck & Co.'s Juvisync

Epix Pharmaceuticals and Amgen S1P1 program assets to be offered for sale

BAY-1017858 shows promise in vitro and in vivo

Abbott enrolls first patients in EXCEL trial evaluating Xience everolimus-eluting stents

FDA and Starpharma agree on phase III program for VivaGel

Victoza launched in China

Trimel Pharmaceuticals provides update on phase II Vibro-Tactile Stimulation trial

Hybrigenics and Servier sign license and collaboration agreement covering multiple fields

Adherex to discuss development of sodium thiosulfate with FDA advisory committee

Biotron provides results from preliminary analysis of BIT-225 study

Paladin Labs completes Labopharm acquisition

Combivent Respimat approved in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...